Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE)

Affiliations

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Young Urological Researchers Organisation, Heidelberg, Australia.
² Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
³ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
⁴ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia. Electronic address: lawrentschuk@gmail.com.

Comment

David C Chen et al. Eur Urol. 2023 Sep.

. 2023 Sep;84(3):353-354.

doi: 10.1016/j.eururo.2023.05.001. Epub 2023 May 24.

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Young Urological Researchers Organisation, Heidelberg, Australia.
² Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
³ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
⁴ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia. Electronic address: lawrentschuk@gmail.com.

No abstract available

Comment on

Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat NA, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N, Faller N, Pellegrini L, Bedino G, Venzin RM, Grosse P, Hüsler C, Koneth I, Bucher C, Del Giorno R, Gabutti L, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Vogt B, Roumet M, Tamò L, Cereghetti GM, Trelle S, Fuster DG. Dhayat NA, et al. N Engl J Med. 2023 Mar 2;388(9):781-791. doi: 10.1056/NEJMoa2209275. N Engl J Med. 2023. PMID: 36856614 Clinical Trial.